Anti-CD8 Antibody, Biotin-Labeled
This purified recombinant antibody is a humanized mouse anti-CD8 a (cluster of differentiation 8 a) antibody. This antibody has a C-terminal Avi-Tag™ on its heavy chain. This antibody recognized human CD8.
Product Specifications
Background
CD8 is a co-receptor for the TCR (T cell receptor) in T cells, binding to MHC (major histocompatibility complex) class I proteins. CD8 is a typical marker of cytotoxic T cells and is involved in signaling. CD8 has two isoforms, a and b. CD8b recruits Lck (lymphocyte-specific protein tyrosine kinase) to the TCR-CD3 complex, and Lck phosphorylates multiple proteins involved in activation of CTLs (cytotoxic T-lymphocytes. It is thus critical for the lysis of cancer cells. Antibodies against CD8 are currently used in the clinic for the diagnostic of cancer, as in the case of crefmirlimab.
UniProt
P01731
Tag
C-terminal Avi-Tag™
Label
This antibody is enzymatically biotinylated using Avi-Tag™ technology. Biotinylation was confirmed to be ≥90%.For more information on enzymatic biotinylation, please see ourTech Note.
Purity
≥ 90%
Format
Aqueous buffer solution.
Shipping Conditions
-80°C
Storage Conditions
At least 6 months at -80°C.
Calculated Molecular Weight
Heavy Chain: 51 kDa; Light Chain: 23 kDa + glycans
Formulation
8 mM phosphate, pH 7.4,110 mM NaCl, 2.2 mM KCl, and 20% glycerol
Glycosylation
This antibody runs at a higher MW by SDS-PAGE due to glycosylation.
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
250331-ML650 100 µL
PPARBP (Mediator Complex Subunit 1, CRSP1, CRSP200, DRIP205, DRIP230, MGC71488, PBP, PPARBP, PPARGBP, RB18A, TRAP220, TRIP2) (MaxLight 650)
Ask
View Details 